Very long-term remission with azacitidine in VEXAS syndrome
Not available.
Saved in:
| Main Authors: | Lin-Pierre Zhao, Vincent Jachiet, Olivier Kosmider, Lise Larcher, Emmanuelle Clappier, Marie Sébert, Lionel Adès, Pierre Hirsch, Thibault Mahévas, Maxime Battistella, Jean-David Bouaziz, Arsène Mekinian, Pierre Fenaux, MINHEMON FRENVEX |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-01-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11923 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of erythroid‐stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX group
by: Maël Heiblig, et al.
Published: (2025-06-01) -
A Clinicopathological Description of Kidney Features in VEXAS Syndrome
by: Martin Mathurin, et al.
Published: (2025-01-01) -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS.
by: Charicleia Kelaidi, et al.
Published: (2011-09-01) -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS.
by: Lionel Ades, et al.
Published: (2011-01-01) -
High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine
by: Francesca Tiso, et al.
Published: (2025-01-01)